Prevalence of premenstrual syndrome and its relationship with blood pressure in young adult females

Abstract

Premenstrual syndrome is a collection of symptoms which women experience 1 to 2 weeks before menstruation which clear with onset of menstrual flow and capable of interfering with life functions. An association between Premenstrual syndrome and hypertension has been suggested leading to the suspicion that it may be one precussor trait of hypertension in the normal population. Since people who develop hypertension later in life start from the higher range of normal earlier on, we sought to find if premenstrual syndrome had any bearing on hypertension. Consenting female subjects in three institutions in Jos, Nigeria were studied. Self-administered questionnaires designed to diagnose premenstrual syndrome and anxio-depressive status were used. Medical, family and menstrual history, as well as height, weight, pulse and blood pressures were documented; and data analysed. Four hundred and fourty seven subjects aged between 17 and 38 years with a mean of 23.6 + 3.9 were studied. Sixty one percent of them satisfied the criteria for diagnosis of premenstrual syndrome. When the data for those in luteal phase was split into the early (1st) and late (2nd) parts, there was a statistically significant rise in systolic and diastolic blood pressure from 1st to 2nd parts only for those with premenstrual syndrome (SBP 107.3 +
11.05 to 111.39 + 13.48 mm Hg. p=0.05 and DBP 65.06 + 10.38 to 70.69 + 10.03. p=0.004). Those with premenstrual syndrome also had higher anxiety and depression scores (chi-square 47.9 and 28.4 respectively). The symptoms of premenstrual syndrome peak in the 2nd part of the luteal phase. They are associated with a lot of stress. Since blood pressure elevation with this change was significantly higher among subjects with premenstrual syndrome, it is felt that premenstrual syndrome may predict future hypertension among currently normotensive females.

Keywords: Premenstrual syndrome, female, hypertension, psychological stress.

Résumé
Le syndrome post menstruel est un ensemble des symptômes que les femmes expérimentent une á deux semaines avant la menstruation et qui finissent après le début des menstrues et capable d’interférer avec les fonctions vitales. L’association entre le syndrome pré menstruel et l’hypertension a été suggère conduisant á la suspicion que ces symptômes peuvent être des signes précurseurs de l’hypertension chez une population normale d’autant que celles qui développent l’hypertension tard dans la vie. Dans cette étude, nous recherchons si le syndrome pré menstruel a un lien avec l’hypertension. Les femelles consenties dans trois institutions dans l’état de Jos, Nigeria étaient étudiés. Des questionnaires étaient administres et utilises pour diagnostiquer le syndrome prémenstruel et le statut anxio-depressive. Autres données telles que l’histoire médicale, familiale et menstruelle bien que la taille le poids, pouls et les pressions sanguines étaient documentées et les données analysées. Quatre cent quarante quatre sujets entre 17- 38 ans avec une moyenne d’age de 23.6±3.9 ans étaient étudies. 61% satisfaisaient les critères du diagnostic du syndrome pre mentruel. A la phase lutéale, les données étaient divisées en deux phase ; la phase précoce (I) et la phase tardive (II). Il y avait une augmentation statistiquement significative de la pression sanguine systolique et diastolique de la phase I a II seulement a celles qui avaient les symptômes pre mentruel (SBP =107±11.05 á 111.39 ± 13.48mmHg, P= 0.05 et DBP= 65.06 - 70.69 ± 10.03mmHg, P=0.004). Celles-ci avaient également des taux anxiété et dépression plus élevées.

Correspondence: Prof. Basil N. Okeahialam, Department of Medicine, Jos University Teaching Hospital, PMB 2076, Jos, Plateau State. Nigeria. Email: basokeam@yahoo.com

pdf

References

Dickson ME and Sigmund CD. Genetic basis of hypertension. Revisiting Angiotensinogen. Hypertens. 2006; 48(1): 14 – 20.

Sert-Kuniyoshi FH and Somers VK. Sleep apnoea in hypertension. When, How and Why should we treat? Hypertens. 2006; 47(5): 818 – 819.

Lillie EO and O’Connor DT. Early changes in hypertension. A role for the autonomic nervous system and heredity. Hypertens. 2006; 47(3): 331 – 333.

Kaplan NM. What can we expect from new guidelines. Med. Clin. N. Amer. 2004; 88: 141 – 148.

Savoia C and Schiffrin EL. Significance of recently identified peptides in hypertension: endothelin, natriuretic peptides, adrenome- dullins, leptid. Med. Clin. N. Amer. 2004; 88 (1): 39 – 62.

Freeman EW. Epidemiology and Etiology of Premenstrual syndromes. http://www.medscape. com/viewarticle/553603?src=mp (posted 03/20/2007)

Ekholm VB and Backstrom T. Influence of premenstrual syndrome on family, social life and work performance. Int. J. Health Serv. 1994; 24(4): 629 – 647.

Kesel B. Premenstrual Syndrome. Advances in diagnosis and treatment. Obstet. Gynaecol. Clin. N. Am. 2000; 27(3): 625 – 629.

Rasheed P and Al-Sowielem LS. Prevalence and predictors of premenstrual syndrome among college aged women in Saudi Arabia. Ann. Saudi Med. 2003; 23(6): 381 – 387.

Okeahialam BN. Predictive value of premenstrual syndrome in hypertension. 1st Pan-African Congress on Hypertension (International Forum for Hypertension Prevention and Control in Africa). Yaounde- Cameroon. 2–5 December 2005. Book of Abstracts p. 16 (Abstract 007).

Andersch B, Swenson A and Hansson L. Preeclampsia, hypertension and the premenstrual tension syndrome. Int. J. Gynaecol. Obstet.1990; 32(2): 123 – 127.

Frohlich ED. Innovative concepts of hypertension to understand and manage the disease (Preface). Med. Clin. N. Amer. 2004; 88: xiii – xxi.

Dickerson RM, Mazyck PJ and Hunter MH. Premenstrual syndrome. Amer. Fam. Physician. 2003; 67: 1743 – 1752.

Zigmond A S and Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scand. 1983; 67: 361 – 370.

Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B and Bliss J. The factor, structure and factor stability of the Hospital Anxiety and Depression Scale in patients with cancer. Br. J. Psych. 1991; 158: 255 – 259.

Abiodun OA. A validity study of Hospital Anxiety and Depression Scale in general out patient units and a community sample in Nigeria.Br. J. Psych. 1994; 165(5): 669 – 672.

Speroff L, Glass RH and Kase NG. Regulation of the menstrual cycle. In: Clinical Gynaecolo- gic Endocrinology and Infertility. 5th Edition.Williams and Wilkins. 1994. Baltimore. Philadelphia, London. Paris. Bangkok. Hong Kong. Munich. Sydney. Tokyo. Wroclaw. 183-230.

Dean BB, Borenstein JE, Knight K and Yonkers K. Evaluating the criteria used for identification of premenstrual syndrome. J.Women’s Health (Larchmt) 2006; 15(5): 546 – 555.

Takeda T, Tasaka K, Sakat M and Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Women Mental Health. 2006; 9(4): 209 – 212.

Tabassum S, Afridi B, Aman Z, Tabassum W and Durrani R. Premenstrual syndrome: Frequency and severity in young college girls. J. Pak. Med. Assoc. 2005; 55(12): 546 – 549.

Steiner M, Macdougall M and Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch. Ment. Health. 2003; 6: 203 – 209.

Antai AB, Udezi AW, Ekanem EE, Okon UJ and Umoiyoho AU. Premenstrual syndrome: prevalence in students of University of Calabar, Nigeria. Afr. J. Biomed. Res. 2004; 7: 45 -50.

Greenberg G, Imeson JD, Thompson SG and Meade TW. Blood pressure and the menstrual cycle. Brit. J. Obstet. Gynaecol. 1985; 92(10): 1010 – 1014.

Andersch B, Hahn L, Anderson M and Isaksson B. Body water and weight in patients with premenstrual syndrome. Br. J. Obstet. Gynaecol. 1978; 85: 546 – 550.

Khan MG. Stress and Heart Disease. In: Khan MG (Ed). Encyclopaedia of Heart Diseases. Elservier Publishers. Amsterdam. Boston. Heidelberg. London. New York. Oxford. Paris. San Diego. San Francisco. Singapore. Sydney. Tokyo. 2006. p. 569 – 573.

Kim DR, Gyulai L, Freeman EW, Morrison MF, Baldassano C and Dube C. Premenstrual dysphoric disease and Psychiatric co-morbiditymorbidity. Arch. Women’s Ment. Health. 2004; 7: 37 – 47.

Kuchel O, Cushe J L, Hamet P, Tollis G, Messerli F H, Barbeau A, Boncher R and Genest J. Labile (borderline) hypertension. New aspects of a common disorder. Angiology 1975; 26(8): 613 – 631.

Matthew K A, Katholi C R, Mc Creath H, Whooley M A, Williams A R, Zhu S and Markovitz JH. Blood pressure reactivity in psychological stress predicts hypertension in the CARDIA study. Circ. 2004; 110: 74 – 78.

Williams RB. Blood pressure reactivity to psychological stress. A new risk factor for coronary disease. Hypertens. 2006; 43(3): 329-330.

Kher N and Maish JD. Pathobiology of atherosclerosis – a brief review. Semin. Thromb. Haemor. 2004; 30: 665 – 672.

Sharma BK, Sherma N and Jain S. Hypertension and the kidneys: interrelationship and therapeutic approach. J. Indian Med. Assoc. 1999; 97(3): 91 – 95, 105.